Suchergebnisse - "Sureda, Anna"

PubPharm (12)

1

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL) : real-life experience with long-term outcomes, toxicities and responses to second-line therapies

enthalten in: International journal of hematology | 2023

von Oliveira, A. | Roncero, J. | Ferrá, C. | +10

2

Editorial : Novel treatments for diffuse large B-cell lymphoma: The post-CART era

enthalten in: Frontiers in immunology | 2022

von Mussetti, A. | Derenzini, E. | Clementine, S. | +1

3

Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

enthalten in: Cancer | 2020

von Jagadeesh, D. | Majhail, N. | He, Y. | +34

ErratumIn: Cancer. 2022 Apr 1;128(7):1547. - PMID 35084045

4

Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution

enthalten in: Leukemia & lymphoma | 2020

von Salas, M. | Mercadal, S. | Domingo Domenech, E. | +8

5

Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL) : results in a homogeneous series from a single institution

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2020

von Salas, M. | Climent, F. | Tapia, G. | +12

6

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation : A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT

enthalten in: JAMA oncology | 2019

von Kanate, A. | Kumar, A. | Dreger, P. | +24

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 30946432

7

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure : A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2018

von Casulo, C. | Friedberg, J. | Ahn, K. | +33

8

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2018

von Epperla, N. | Ahn, K. | Armand, P. | +10

9

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

enthalten in: Journal of hematology & oncology | 2017

von Epperla, N. | Ahn, K. | Ahmed, S. | +12

10

Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2015

von Klyuchnikov, E. | Bacher, U. | Kröger, N. | +28